81 to 90 of 1,739 Results
Adobe PDF - 414.6 KB -
MD5: 80c438fe984e22965eed9684d92e970d
This file contains methodologies and results that were not included in the final manuscript. It includes data from infrared spectroscopy (FTIR-ATR), validation of the analytical method for eugenol, thermodynamic stability at time points of 0, 45, and 90 days, results from the cho... |
MS Excel Spreadsheet - 33.0 KB -
MD5: 9db12060ac0641888776f2a1522a4d13
Division of the specimens for the application of the treatment groups |
MS Excel Spreadsheet - 32.0 KB -
MD5: fad27b83091e6ede95e9f7152bf509c3
Physico-chemical characterization of the formulations (NFE and NFW) |
MS Excel Spreadsheet - 33.0 KB -
MD5: 6a18a85684502665a59f7469907c37ca
Inhibitory effect of nanostructured formulations (NFE and NFW) and eugenol against Candida strains |
Adobe PDF - 40.9 MB -
MD5: d08e918527016c35d1ea299bf1ae29be
|
Adobe PDF - 41.1 MB -
MD5: 9091a3e69922f8a6226960b44d4623a5
|
Adobe PDF - 104.2 KB -
MD5: e6a8e8a2ad3efcffabfc9ae87ee36dfb
|
Adobe PDF - 804.2 KB -
MD5: 007e6476da7bc566fbf31711e017744e
Supplementary Material of the Article "An integrative review on treatment guidelines for complicated urinary tract infections: a synthesis of evidence-based recommendations" |
Adobe PDF - 447.9 KB -
MD5: 3ba2cf4dda9594014b76f25018846719
|
Jan 22, 2025 -
Data for: REBEn 2022-0134: Prevalência dos fatores de risco para Hemorragia Pós-parto primária em um hospital universitário
Adobe PDF - 2.6 MB -
MD5: 0631440fa9725e6f5ef821cf2ed8e884
|